Physician

Apoor Suresh Gami, M.D.

According to 2025 Medicare claims, Apoor Gami, M.D. (NPI: 1326026840) practices cardiac electrophysiology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Du Page, IL. This provider's primary affiliated billing organization is MIDWEST CARDIOVASCULAR INSTITUTE SC (NPI: 1003491549; TIN: 861664195) and primary practice location at 60126-5659. Gami is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), participating under the MSSP model.

Gami's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,432 traditional Medicare patients, billed 8,749 HCPCS/CPT codes, and received $535,795 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 6,082 prescription claims across 920 beneficiaries totaling $1,788,532 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 27 claims. Open Payments data shows 49 records totaling $12,664. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $337,066 to $1,788,532. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,586	5,379	$324,024
2016	3,322	6,831	$311,531
2017	3,299	6,957	$373,117
2018	2,202	4,774	$319,985
2019	2,302	4,880	$323,621
2020	2,302	4,337	$230,840
2021	1,571	4,257	$261,481
2022	1,304	6,764	$514,201
2023	1,190	7,082	$477,633
2024	1,432	8,749	$535,795

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	386	2,625	$337,066
2016	429	2,994	$409,797
2017	529	3,708	$632,545
2018	550	3,734	$746,121
2019	598	4,020	$845,904
2020	565	3,973	$917,694
2021	589	3,863	$1,046,508
2022	656	4,204	$1,217,632
2023	756	4,825	$1,501,278
2024	920	6,082	$1,788,532

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	20	$42,185
2016	N/R	16	$30,011
2017	N/R	27	$52,057
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	531	552	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	681	1,039	$98
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	358	1,181	$16
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	705	1,125	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	607	972	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	680	40,833	$777,868
Xarelto	Rivaroxaban	356	23,103	$417,385
Multaq	Dronedarone Hcl	145	8,206	$214,936
Entresto	Sacubitril/Valsartan	147	8,895	$194,380
Propafenone Hcl Er	Propafenone Hcl	115	8,568	$20,043

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$12,664	JAZZ PHARMACEUTICALS INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Apoor Suresh Gami, M.D.?

Tedicare shows public-source Medicare data for Apoor Suresh Gami, M.D. (NPI 1326026840), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Apoor Suresh Gami, M.D. have ACO affiliation data?

Apoor Suresh Gami, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033).

What billing organization is linked to Apoor Suresh Gami, M.D.?

Apoor Suresh Gami, M.D. is linked to MIDWEST CARDIOVASCULAR INSTITUTE SC (billing NPI 1003491549) in the available physician profile data.

Does Apoor Suresh Gami, M.D. have Open Payments data?

Apoor Suresh Gami, M.D. has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.